Abstract
A 34-yr-old Caucasian female was managed by her primary physician for a history of Addison’s disease and hypothyroidism. She was admitted in August with a 4 d history of generalized weakness, postural lightheadedness, and a marked increase in muscle cramping.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Goland RS, Wardlaw SL, Stark RE, et al. High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. J Clin Endocrinol Metab 1986; 63: 1199–1203.
Magiakou MA, Mastorakos G, Rabin D, et al. Placental CRH secretion and the maternal hypothalamicpituitary-adrenal axis in human pregnancy. Clin Endocrinol 1996; 44: 419–428.
Suda T, Iwashita M, Tozawa F, et al. Characterization of corticotropin-releasing hormone binding protein in human plasma by chemical cross-linking and its binding during pregnancy. J Clin Endocrinol Metab 1988; 67: 1278–1283.
Linton EA, Perkins AV, Woods RJ, et al. Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy J Clin Endocrinol Metab 1993; 76: 260–262.
Demey-Ponsart E, Foidart JM, Sulon J, et al. Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy. J Steroid Biochem 1982; 16: 165–169.
Don HG, Heller A, Versmold HT, et al. Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy. J Clin Endocrinol Metab 1989; 68: 863–868.
Whiteley HJ, Stoner HB. The effect of pregnancy on the adrenal cortex. J Endocrinol 1957; 14: 325.
Rosenthal HE, Slaunwhite WR, Sandberg AA. Transcortin, a corticosteroid-binding protein of plasma: Cortisol and progesterone interplay and unbound levels of these steroids in pregnancy. J Clin Endocrinol Metab 1969; 29: 352–367.
Wilson M, Morganti AA, Zervoudakis I, et al. Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med 1980; 8: 97–104.
Gant NF, Daley GL, Chand S, et al. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973; 52: 2682–2689.
Ehrlich EN, Lindheimer MD. Effect of administered mineralocorticoids or ACTH in pregnant women. Attenuation of kaliuretic influence of mineralocorticoids during pregnancy. J Clin Invest 1972; 51: 1301 1309.
Jones KM, Lloyd-Jones R, Riondel A, et al. Aldosterone secretion and metabolism in normal men and women and in pregnancy. Acta Endocrinol 1959; 30: 321.
Biglieri EG, Slaton Jr, PE. Pregnancy and primary aldosteronism. J Clin Endocrinol Metab 1967; 27: 1628–1632.
Gamlen TR, Aynsley-Green A, Irvine WJ, McCallum CJ. Immunological studies in the neonate of a mother with Addison’s disease and diabetes mellitus. Clin Exp Immunol 1977; 28: 192–195.
Osler M. Addison’s disease and pregnancy. Acta Endocrinol 1962; 41: 67.
Normington EM, Davies D. Hypertension and oedema complicating pregnancy in Addison’s disease. Br Med J 1972; 1: 148–149.
Freier DT, Thompson NW. Pheochromocytoma and pregnancy: the epitome of high risk. Surgery 1993; 114: 1148–1152.
Saarikoski S. Fate of noradrenaline in the human fetoplacental unit. Acta Physiol Scand 1974; 421 (Suppl): 1–84.
Dahia PLM, Hayashida CY, Strunz C, Abelin N, Toledo SPA. Low cord blood levels of catecholamine from a newborn of a pheochromocytoma patient. Eur J Endocrinol 1994; 130: 217–219.
Barzel US, Barlian Z, Runmery G, et al. Pheochromocytoma and pregnancy. Am J Obstet Gynecol 1964; 89: 519–521.
Bakri YN, Ingemansson SE, Ali A, Parikh S. Pheochromocytoma and pregnancy: report of three cases. Acta Obstet Gynecol Scand 1992; 71: 301–304.
Harper MA, Murnaghan GA, Kennedy L, Hadden DR, Atkinson AB. Phaeochromocytoma in pregnancy: five cases and a review of the literature. Br J Obstet Gynaecol 1989; 96: 594–606.
Combs CA, Easterling TR, Schmucker BC. Hemodynamic observations during paroxysmal hypertension in a pregnancy with pheochromocytoma. Obstet Gynecol 1989; 74: 439–442.
Falterman CJ, Kreisberg R. Pheochromocytoma: clinical diagnosis and management. South Med J 1982; 75: 321–328.
Baysal BE, Willett-Brozick JE, Lawrence EC, et al. Genetic heterogeneity in hereditary paraganglioma (PGL): SDHD is the primary locus in imprinted PGL pedigrees. Am J Hum Genet 2000; 66 (Suppl): 385f.
Kalff V, Shapiro B, Lloyd R, et al. The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis. Arch Intern Med 1982; 142: 2092–2098.
Kothari A, Bethune M, Manwaring J, Astley N, Wallace E. Massive bilateral phaeochromocytomas in association with von Hippel Lindau syndrome in pregnancy. Aust NZ J Obstet Gynaecol 1999; 39: 38 1384.
Freier DT, Eckhauser FE, Harrison TS. Pheochromocytoma. Arch Surg 1980; 115: 388–391.
Pederson EB, Rasmussen AB, Christensen NJ, et al. Plasma noradrenaline and adrenaline in pre-eclampsia, essential hypertension in pregnancy and normotensive pregnant control subjects. Acta Endocrinol (Copenh) 1982; 99: 594–600.
Zuspan FP. Urinary excretion of epinephrine and norepinephrine during pregnancy. J Clin Endocrinol Metab 1970; 30: 357–360.
Sheps SG, Jiang NS, Klee GC. Diagnostic evaluation of pheochromocytoma. Endocrinol Metab Clin North Am 1988; 17: 397–415.
Devoe LD, O’Dell BE, Castillo RA, Hadi HA, Searle N. Metastatic pheochromocytoma in pregnancy and fetal biophysical assessment after maternal administration of alpha-adrenergic, beta-adrenergic, and dopamine antagonists. Obstet Gynecol 1986; 68 (Suppl 3): 15S - 18S.
Santeiro ML, Stromquist C, Wyble L. Phenoxybenzamine placental transfer during the third trimester. Ann Pharmacother 1996; 30: 1249–1251.
Lyons CW, Colmorgen GHC. Medical management of pheochromocytoma in pregnancy. Obstet Gynecol 1988; 72: 450–451.
Ahlawat SK, Jain S, Kumari S, Varma S, Sharma BK. Pheochromocytoma associated with pregnancy: case report and review of the literature. Obstet Gynecol Sury 1999; 54: 728–737.
Chatterjee TK, Parekh U. Phaeochromocytoma in pregnancy. Aust NZ J Obstet Gynaecol 1985; 25: 290291
Finkenstedt G, Gasser RW, Hofle G, et al. Pheochromocytoma and sub-clinical Cushing’s syndrome during pregnancy: diagnosis, medical pre-treatment and cure by laparoscopie unilateral adrenalectomy. J Endocrinol Invest 1999; 22: 551–557.
Schenker JG, Granat M. Phaeochromocytoma and pregnancy-An updated appraisal. Aust NZ J Obstet Gynaecol 1982; 22: 1–10.
Schenker JG, Chowers I. Pheochromocytoma and pregnancy: review of 89 cases. Obstet Gynecol Sury 1971; 26: 739–747.
Raue F, Bayer JM, Rahn KH, et al. Hypercalcitoninaemia in patients with pheochromocytoma. Klin Wochenschrift 1978; 56: 697–701.
Heath H, Edis AJ. Pheochromocytoma associated with hypercalcemia and ectopic secretion of calcitonin. Ann Intern Med 1979; 91: 208–210.
Kato T, Seki K, Matsui H, Sekiya S. Monometric calcitonin in pregnant women and in cord blood. Obstet Gynecol 1998; 92: 241–244.
Pitkin RM. Calcium metabolism pregnancy: a review. Am J Obstet Gynecol 1985; 151: 99.
Okah FA, Tsang RC, Sierra R, Brady KK, Specker BL. Bone turnover and mineral metabolism in the last trimester of pregnancy: effect of multiple gestation. Obstet Gynecol 1996; 88: 168–173.
Mestman JH. Hyperthyroidism in pregnancy. Endocrinol Metab Clinics N Am 1998; 27: 127–149.
Goldstein DE, Drash A, Gibbs J, Blizzard RM. Diabetes mellitus: the incidence of circulating antibodies against thyroid, gastric, and adrenal tissue. J Pediatr 1970; 77: 304–306.
Bech K, Hoier-Madsen M, Feldt-Rasmussen U, et al. Thyroid function and autoimmune manifestations in insulin-dependent diabetes mellitus during and after pregnancy. Acta Endocrinologia 1991; 124: 534539.
Bouillon R, Naesens M, Van Assche FA, et al. Thyroid function in patients with hyperemesis gravidarum. Am J Obstet Gynecol 1982; 143: 922–926.
Chin RK, Lao TT. Thyroxine concentrations and outcome of hyperemetic pregnancies. Br J Obstet Gynaecol 1988; 95: 507–509.
Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab 1992; 75: 1333–1339.
Yoshimura M, Hershman JM. Thyrotropic action of human chorionic gonadotropin. Thyroid 1995; 5: 425–434.
Tsuruta E, Tada H, Tamaki H, et al. Pathogenic role of asial human chroionic gonadotropin in gestational thyrotoxicosis. J Clin Endocrinol Metab 1995; 80: 350–355.
Goodwin TM, Montoro M, Mestman JH. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 1992; 167: 648–652.
Glinoer D, DeNayer P, Bourdoux P, et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 1990; 71: 276–287.
Merio R, Festa A, Bergmann H, et al. Slow gastric emptying in type I diabetes: relation to autonomic and peripheral neuropathy, blood glucose and glycemic control. Diabetes Care 1997; 20: 419–423.
Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology 1988; 94: 739–744.
Hornbuckle K, Barnett JL. The diagnosis and work-up of the patient with gastroparesis. J Clin Gastroenterol 2000; 30: 117–124.
Barker DJP, Gluckman PD, Godfrey KM, et al. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993; 341: 938–941.
Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clarke PMS. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to reduced fetal growth. Diabetologia 1993;36:62–67.
Rabine JC, Barnett JL. Management of the patient with gastroparesis. J Clin Gastroenterol 2001; 32: 11–18.
Lavin Jr JP, Gimmon Z, Miodovnik M, von Meyenfeldt M, Fischer JE. Total parenteral nutrition in a pregnant insulin-requiring diabetic. Obstet Gynecol 1982; 59: 660–664.
Zibell FD, Jen KL, Rick J. Use of parenteral nutrition to maintain adequate nutritional status in hyperemesis gravidarum. J Perinatol 1990; 10: 390–395.
Kirby DF, Fiorenza V, Craig RM. Intravenous nutritional support during pregnancy. J Parentr Enteral Nutr 1988; 12: 72–80.
Scott AR, Tattersall RB, McPherson M. Improvement of postural hypotension and severe diabetic autonomic neuropathy during pregnancy. Diabetes Care 1988; 11: 369–370.
Phelps RL, Sakol P, Metzger BE, Jampol LM, Freinkel N. Changes in diabetic retinopathy during pregnancy. Correlations with regulation of hyperglycemia. Arch Ophthalmol 1986; 104: 1806–1810.
Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy: The Diabetes In Early Pregnancy Study. Diabetes Care 1995; 18: 631–637.
The Kroc Collaborative Study Group: Blood glucose control and the evolution of diabetic retinopathy and albuminuria. N Engl J Med 1984; 311: 365–372.
Diabetes Control and Complications Trial Research Group. Pregnancy increases the risk of complications in the DCCT. Am J Obstet Gynecol 2000.
Reece EA, Coustan DR, Hayslett JP, et al. Diabetic nephropathy: pregnancy performance and feto-maternal outcome. Am J Obstet Gynecol 1988; 159: 56–66.
McCance DR, Traub AI, Harley JM, Hadden DR, Kennedy L. Urinary albumin excretion in diabetic pregnancy. Diabetologia 1989; 32: 236–239.
Biesenbach G, Stöger H, Zazgornik J. Influence of pregnancy on progression of diabetic nephropathy and subsequent requirement of renal replacement therapy in female type I diabetic patients with impaired renal function. Nephrol Dial Transplant 1992; 7: 105–109.
Purdy LP, Hantsch CE, Molitch ME, et al. Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency. Diabetes Care 1996; 19: 1067–1074.
Ariza-Andraca CR, Altamirano-Bustamante E, Frati-Munari AC, Altamirano-Bustamante P, GraefSanchez A. Delayed insulin absorption due to subcutaneous edema. Arch Investig Med 1991; 22: 229–233.
Burrow G. Thyroid function and hyperfunction during gestation. Endocrinol Revs 1993; 14: 194–202.
Mestman JH. Hyperthyroidism in pregnancy. Clin Obstet Gynecol 1997; 40: 45–64.
Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Wallenstein S, Davies TF. A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunction. J Clin Endocrinol Metab 1992; 74: 645–653.
Burrow GN. Thyroid diseases. In: Burrow GN, Duffy TP, eds. Medical Complications During Pregnancy, 5th edition. WB Saunders, Philadelphia, PA, 1999, pp. 135–161.
Sridama V, Pacini F, Yang SL, Moawad A, Reilly M, DeGroot LJ. Decreased levels of helper T cells: a possible cause of immunodeficiency in pregnancy. N Engl J Med 1982; 307: 352–356.
Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994; 84: 946–949.
Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 1989; 160: 63–70.
Gardner DF, Cruikshank DP, Hays PM, Cooper DS. Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests. J Clin Endocrinol Metab 1986; 62: 217–220.
Hales IB, McElduff A, Crummer P, et al. Does Graves’ disease or thyrotoxicosis affect the prognosis of thyroid cancer? J Clin Endocrinol Metab 1992; 75: 886–889.
Pacini F, Elisei R, Di Coscio GC, et al. Thyroid carcinoma in thyrotoxic patients treated by surgery. J Endocrinol Invest 1988; 11: 107–112.
Belfiore A, Garofalo MR, Giuffrida D, et al. Increased aggressiveness of thyroid cancer in patients with Graves’ disease. J Clin Endocrinol Metab 1990; 70: 830–835.
Behar R, Arganini M, Wu TC, et al. Graves’ disease and thyroid cancer. Surgery 1986; 100: 1121–1127.
Pellegriti G, Belfiore A, Giuffrida D, et al. Outcome of differentiated thyroid cancer in Graves’ patients. J Clin Endocrinol Metab 1998; 83: 2805–2809.
Ozaki O, Ito K, Kobayashi K, et al. Thyroid carcinoma in Graves’ disease. World J Surg 1990; 14: 437–441.
Filetti S, Belfiore A, Amir SM, et al. The role of thyroid-stimulating antibodies of Graves’ disease in differentiated thyroid cancer. N Engl J Med 1988; 318: 753–759.
Struve CW, Haupt S, Ohlen S. Influence of frequency of previous pregnancies on the prevalence of thyroid nodules in women without clinical evidence of thyroid disease. Thyroid 1993; 3: 7–9.
McTiernan AM, Weiss NS, Daling JR. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am J Epidemiol 1984; 120: 423–435.
Akslen LA, Nilssen S, Kva’le G. Reproductive factors and risk of thyroid cancer: a prospective study of 63,090 women from Norway. Br J Cancer 1992; 65: 772–774.
Herzon FS, Morris DM, Segal MN, Rauch G, Parnell T. Coexistent thyroid cancer and pregnancy. Arch Otolaryngol Head Neck Surg 1994; 120: 1191–1193.
Mestman JH, Goodwin M, Montoro MM. Thyroid disorders of pregnancy. Endocrinol Metab Clin N Am 1995; 24: 41–71.
Rosen IB, Walfish PG. Pregnancy as a predisposing factor in thyroid neoplasia. Arch Surg 1986; 121: 1287–1290.
Rosen IB, Walfish PG, Nikore V. Pregnancy and surgical thyroid disease. Surgery 1985; 98: 1135–1140.
Hay I. Nodular thyroid disease diagnosed during pregnancy: how and when to treat. Thyroid 1999; 9: 667670.
Kobayashi K, Tanaka Y, Ishiguro S, Mori T. Rapidly growing thyroid carcinoma during pregnancy. J Surg Oncol 1994; 55: 61–64.
Eskin BA, Parker JA, Bassett JG, George DL. Human breast uptake of radioactive iodine. Obstet Gynecol 1974; 44: 398–402.
Tazebay UH, Wapnir IL, Levy O, et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 2000; 6: 871–878.
Dydek GJ, Blue PW. Human breast milk excretion of iodine-131 following diagnostic and therapeutic administration to a lactating patient with Graves’ disease. J Nucl Med 1988; 29: 407–410.
Doody RE, Becker DV, Brill AB, et al. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 1998; 280: 347–355.
Toft AD, Irvine WJ, McLeod DAD, Seth J, Cameron EHD, Lidard GP. Propranolol in the treatment of thyrotoxicosis by subtotal thyroidectomy. J Clin Endocrinol Metab 1976; 43: 1312–1316.
Caswell HT, Marks AD, Channick BJ. Propranolol for the preoperative preparation of patients with thyrotoxicosis. Surg Gynecol Obstet 1978; 146: 908–910.
Marigold JH, Morgan AK, Earle DJ, Young AE, Croft DN. Lugol’s iodine: its effect on thyroid blood flow in patients with thyrotoxicosis. Br J Surg 1985; 72: 45–47.
Marmon L, Au FC. The preoperative use of iodine solution in thyrotoxic patients prepared with propranolol. Is it necessary? Am Surg 1989; 55: 629–631.
Kaur S, Parr JH, Ramsay ID, Hennebry TM, Jarvis KJ, Lester E. Effect of preoperative iodine in patients with Graves’ disease controlled with antithyroid drugs and thyroxine. Ann R Coll Surg Engl 1988; 70: 123–127.
Delange F. Administration of iodized oil during pregnancy: a summary of the published evidence. Bull WHO 1996; 74: 101–108.
Hollowell JG, Staehling NW, Hannon WH, et al. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971–1974 and 1988–1994). J Clin Endocrinol Metab 1988; 83: 3401–3408.
Glinoer D, De Nayer P, Delange F, et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. J Clin Endocrinol Metab 1995; 80: 258–269.
Klett M, Ohlig M, Manz F, Troeger J, Heinrich U. Effect of iodine supply on neonatal thyroid volume and TSH. Acta Paediatr Suppl 1999; 432: 18–20.
Nohr SB, Laurberg P. Opposite variations in maternal and neonatal thyroid function induced by iodine supplementation during pregnancy. J Clin Endocrinol Metab 2000; 85: 623–627.
Weber G, Vigone MC, Rapa A, et al. Neonatal transient hypothyroidism: aetiological study. Arch Dis Child Fetal Neonatal Ed 1998; 79: F70 - F72.
Danziger Y, Pertzelan A, Mimouni M. Transient congenital hypothyroidism after topical iodine in pregnancy and lactation. Arch Dis Child 1987; 62: 295–296.
Brown RS, Bloomfield S, Bednarek FJ, Mitchell ML, Braverman LE. Routine skin cleansing with povidone-iodine is not a common cause of transient neonatal hypothyroidism in North America: a prospective controlled study. Thyroid 1997; 7: 395–400.
Senior B, Chernoff HL. Iodide goiter in the newborn. Pediatr 1971; 47: 510–515.
Momotani N, Hisaoka T, Noh J, Ishikawa N, Ito K. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves’ disease complicated by pregnancy. J Clin Endocrinol Metab 1992; 75: 738–744.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Purdy, L.P., Metzger, B.E. (2002). Endocrine Problems in Pregnancy. In: Molitch, M.E. (eds) Challenging Cases in Endocrinology. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-277-7_15
Download citation
DOI: https://doi.org/10.1007/978-1-59259-277-7_15
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-249-0
Online ISBN: 978-1-59259-277-7
eBook Packages: Springer Book Archive